why choose us

Clinical Trials Search

Showing 5,010 of 132,085 result(s)
Treatment of Peri-implant Bone Dehiscence Using Autogenous Tooth Plate

Status: COMPLETED

Condition: Implant Complication

Interventions: the dehisced bone defect will be covered with duoteck membrane

Date: 2024-03-09

PCOS Patients' Immune Alterations

Status: COMPLETED

Condition: Polycystic Ovary Syndrom

Interventions: Flow cytometry was used to detect the immune function of peripheral blood samples of PCOS patients.

Date: 2024-03-08

Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

Status: COMPLETED

Condition: Diabetes Mellitus, Type 2

Interventions: Vitamin D3 (cholecalciferol), 1600 IU per day.

Date: 2024-03-08

FlexStone Enabled Kidney Stone Retrieval

Status: COMPLETED

Condition: Kidney Calculi

Interventions: Using FlexStone Basket aimability to retrieve kidney stones

Date: 2024-03-08

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated

Status: COMPLETED

Condition: Healthy

Interventions: BI 3006337

Date: 2024-03-08

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants

Status: COMPLETED

Condition: Healthy Participants Study

Interventions: AZD0292 will be administered as single dose via IV infusion.

Date: 2024-03-08

A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

Status: COMPLETED

Condition: Respiratory Syncytial Virus

Interventions: RSVpreF vaccine

Date: 2024-03-08

Ameliorative Potential of Relaxing Back Massage on Puerperial Women's Hormones and Infant Weight

Status: COMPLETED

Condition: Does Postpartum Massage Affect Leptin, Prolactin and Growth Hormone

Interventions: Effleurage massage from shoulders toward lower back

Date: 2024-03-08

Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study

Status: COMPLETED

Condition: Axial Spondyloarthritis

Interventions: Tofacitinib (JAKi) is a targeted therapy option for patients with refractory ax-SpA.

Date: 2024-03-08